Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1147 participants.

Also called NCT01131182

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,147 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01131182
Other papers using this trial's data
  • The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial International journal of clinical practice, 2011-11 DOI, PubMed 21951832, PMC3253336 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01131182. Randomized; no masking; primary purpose treatment. Start 2010-06-13 (actual); primary completion 2010-11-04 (actual). Results posted on 2012-01-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
Condition
Type 2 Diabetes Mellitus (T2DM)
Intervention (Drug)
Sitagliptin phosphate
Intervention (Drug)
Comparator: Sulfonylurea
Intervention (Drug)
Metformin
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct01131182
Content hash
da3248494e98d1e6a8bbe1815afb43bf7a571c56b8aff4cb8cafd6620789e0e2